Modular programming for tuberculosis control, the “AuTuMN” platform
Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity a...
Saved in:
| Published in: | BMC infectious diseases Vol. 17; no. 1; pp. 546 - 12 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
07.08.2017
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-2334, 1471-2334 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain.
Results
We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions (“AuTuMN”). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A “Model runner” module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application.
Conclusions
The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. |
|---|---|
| AbstractList | Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain. Results We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions (“AuTuMN”). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A “Model runner” module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application. Conclusions The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. Abstract Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain. Results We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions (“AuTuMN”). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A “Model runner” module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application. Conclusions The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. Tuberculosis (TB) is now the world's leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain. We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions ("AuTuMN"). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A "Model runner" module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application. The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain. Results We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions (“AuTuMN”). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A “Model runner” module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application. Conclusions The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. Tuberculosis (TB) is now the world's leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain.BACKGROUNDTuberculosis (TB) is now the world's leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain.We adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions ("AuTuMN"). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A "Model runner" module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application.RESULTSWe adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions ("AuTuMN"). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A "Model runner" module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application.The modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB.CONCLUSIONSThe modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB. |
| ArticleNumber | 546 |
| Audience | Academic |
| Author | Trauer, James McCracken McBryde, Emma Sue Doan, Tan Nhut Ragonnet, Romain |
| Author_xml | – sequence: 1 givenname: James McCracken surname: Trauer fullname: Trauer, James McCracken email: james.trauer@monash.edu organization: School of Public Health and Preventive Medicine, Monash University – sequence: 2 givenname: Romain surname: Ragonnet fullname: Ragonnet, Romain organization: The Burnet Institute – sequence: 3 givenname: Tan Nhut surname: Doan fullname: Doan, Tan Nhut organization: Department of Medicine, Clinical Sciences Building, the Royal Melbourne Hospital – sequence: 4 givenname: Emma Sue surname: McBryde fullname: McBryde, Emma Sue organization: Australian Institute of Tropical Health and Medicine, James Cook University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28784094$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkstu1DAUhiNURC_wAGxQJDYgkRI7ji8bpFEFZaSWSlDYWr6mHiXx1E4Q7Pog8HJ9EhymlEkFCHlhy_7-3zrn_PvZTu97k2WPQXkIAMUvI4CUsKIEpIAY0QLfy_YAIqCAVYV2ts672X6MqzKBFLIH2W6SUVQytJcdn3o9tiLk6-CbILrO9U1ufciHUZqgxtZHF3Pl-yH49kU-XJj8-urbYjwfT99dX33P160YEt49zO5b0Ubz6GY_yD6-eX1-9LY4OTteHi1OCoUJGArGoKwpEJRomkqwthSUWqwFlErqmmJFtUQMVILVkmJQEoElwUhbiKE2oDrIlhtf7cWKr4PrRPjKvXD854UPDRdhcKo1XAOMhYbKEFAiWVmBkaSaUWGwRVpOXq82XutRdkYrk4oU7cx0_tK7C974z7yuEUGkSgbPbgyCvxxNHHjnojJtK3rjx8gBg6QqcQVYQp_eQVd-DH1qVaIqVGPKqvI31YhUgOutT_-qyZQvagDSkAmGiTr8A5WWNp1LozLWpfuZ4PlMMI3TfBkaMcbIlx_e_z979mnOPtlu4G3nfsUrAWADqOBjDMbeIqDkU4T5JsI8JZNPEeY4acgdjXKDGNwUQeHafyrhRhnTL31jwlaP_yr6AdWHA4U |
| CitedBy_id | crossref_primary_10_1017_S0950268819001857 crossref_primary_10_1016_j_swevo_2020_100717 crossref_primary_10_1177_0272989X18807438 crossref_primary_10_1155_2021_5089184 crossref_primary_10_1016_j_future_2020_07_005 crossref_primary_10_1016_j_lanwpc_2022_100563 crossref_primary_10_1093_ije_dyac045 crossref_primary_10_1038_s41598_021_83768_y crossref_primary_10_1016_j_asoc_2023_111134 crossref_primary_10_3390_healthcare10030473 crossref_primary_10_1186_s12879_022_07067_1 crossref_primary_10_1371_journal_pcbi_1009255 crossref_primary_10_1016_j_epidem_2021_100470 crossref_primary_10_3390_tropicalmed4020071 crossref_primary_10_2478_amns_2023_1_00473 crossref_primary_10_1186_s12916_023_02785_y |
| Cites_doi | 10.1016/S0140-6736(01)06076-7 10.1136/sti.2004.010157 10.1016/j.chest.2015.11.017 10.1128/CMR.00042-10 10.1186/1471-2458-13-97 10.1136/sti.2006.020164 10.1136/sti.2010.044784 10.5588/ijtld.12.0573 10.1001/jama.283.19.2537 10.1136/sextrans-2012-050640 10.1183/09031936.00145411 10.1086/591974 10.1016/S2214-109X(16)30199-1 10.7554/eLife.02565 10.1056/NEJMra1413919 10.1016/S2213-8587(14)70109-3 10.1097/QAI.0000000000000605 10.1136/sti.2004.010165 10.1016/j.ijid.2017.01.031 10.1186/s12916-016-0723-2 10.1093/ije/dyq016 10.5588/ijtld.11.0062 10.1093/pch/8.10.624 10.5588/pha.14.0087 10.1136/sti.2006.020230 10.1016/S2214-109X(16)30265-0 10.1371/journal.pcbi.1000656 10.1093/aje/kwv323 10.1016/j.jtbi.2014.05.023 10.1001/archinte.163.9.1009 10.1086/338342 10.1016/S0140-6736(10)61505-X 10.1016/S0140-6736(06)68383-9 10.1038/srep15468 10.1371/journal.pone.0017601 10.1016/S0140-6736(15)00151-8 10.1186/1471-2458-13-940 10.1186/s12916-016-0608-4 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2017 COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 |
| Copyright_xml | – notice: The Author(s). 2017 – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12879-017-2648-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1471-2334 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_d166ad2ce7104b3fa64b8d98ae6f4db1 PMC5547473 A511264762 28784094 10_1186_s12879_017_2648_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: The Global Fund to Fight AIDS, Tuberculosis and Malaria grantid: SI-VfM – fundername: ; grantid: SI-VfM |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QL 7T2 7U9 7XB 8FK AHSBF AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c671t-992b581a87d8118ff0a88f6da2bcbd586c8db4913a95b86107a6b764df262de13 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 12 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000407072100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2334 |
| IngestDate | Mon Nov 10 04:26:27 EST 2025 Tue Nov 04 01:55:44 EST 2025 Fri Sep 05 08:30:25 EDT 2025 Mon Oct 06 18:28:36 EDT 2025 Tue Nov 11 10:55:58 EST 2025 Tue Nov 04 18:15:36 EST 2025 Thu Nov 13 16:16:05 EST 2025 Thu Nov 13 16:19:40 EST 2025 Thu Jan 02 23:11:59 EST 2025 Sat Nov 29 03:13:50 EST 2025 Tue Nov 18 22:14:49 EST 2025 Sat Sep 06 07:29:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Global health Tuberculosis, multidrug-resistant Software Tuberculosis Disease transmission, infectious Models, biological |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c671t-992b581a87d8118ff0a88f6da2bcbd586c8db4913a95b86107a6b764df262de13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/d166ad2ce7104b3fa64b8d98ae6f4db1 |
| PMID | 28784094 |
| PQID | 1934568930 |
| PQPubID | 42582 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d166ad2ce7104b3fa64b8d98ae6f4db1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5547473 proquest_miscellaneous_1927306319 proquest_journals_1934568930 gale_infotracmisc_A511264762 gale_infotracacademiconefile_A511264762 gale_incontextgauss_ISR_A511264762 gale_incontextgauss_IOV_A511264762 pubmed_primary_28784094 crossref_primary_10_1186_s12879_017_2648_6 crossref_citationtrail_10_1186_s12879_017_2648_6 springer_journals_10_1186_s12879_017_2648_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-08-07 |
| PublicationDateYYYYMMDD | 2017-08-07 |
| PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationSubtitle | BMC series – open, inclusive and trusted |
| PublicationTitle | BMC infectious diseases |
| PublicationTitleAbbrev | BMC Infect Dis |
| PublicationTitleAlternate | BMC Infect Dis |
| PublicationYear | 2017 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | 2648_CR26 2648_CR27 2648_CR24 2648_CR46 2648_CR25 2648_CR47 2648_CR28 2648_CR29 2648_CR40 2648_CR41 GP Garnett (2648_CR7) 2011; 378 2648_CR22 2648_CR44 2648_CR23 2648_CR45 2648_CR20 2648_CR42 2648_CR21 2648_CR43 World Health Organization (2648_CR1) 2016 World Health Organization (2648_CR3) 2015 2648_CR37 2648_CR16 2648_CR38 2648_CR13 2648_CR35 2648_CR14 2648_CR36 2648_CR19 2648_CR4 2648_CR17 2648_CR39 2648_CR5 2648_CR18 JM Trauer (2648_CR15) 2016; 149 2648_CR30 2648_CR11 2648_CR33 2648_CR12 2648_CR34 2648_CR31 2648_CR10 2648_CR32 World Health Organization (2648_CR2) 2014 2648_CR6 2648_CR8 2648_CR9 20019856 - Paediatr Child Health. 2003 Dec;8(10):624-6 20126529 - PLoS Comput Biol. 2010 Jan 29;6(1):e1000656 20348129 - Int J Epidemiol. 2010 Apr;39 Suppl 1:i7-10 23172341 - Sex Transm Infect. 2012 Dec;88 Suppl 2:i11-6 24021245 - Health Technol Assess. 2013 Sep;17 (37):1-372, v-vi 11567729 - Lancet. 2001 Sep 15;358(9285):912-6 23374118 - BMC Public Health. 2013 Feb 02;13:97 27012808 - BMC Med. 2016 Mar 24;14 :56 11807725 - J Infect Dis. 2002 Feb 1;185(3):401-4 22005924 - Eur Respir J. 2012 Jun;39(6):1425-31 21481448 - Lancet. 2011 Aug 6;378(9790):515-25 24898755 - Elife. 2014 Jun 04;3:null 21482729 - Clin Microbiol Rev. 2011 Apr;24(2):351-76 10815117 - JAMA. 2000 May 17;283(19):2537-45 16735294 - Sex Transm Infect. 2006 Jun;82 Suppl 3:iii51-55 24103508 - BMC Public Health. 2013 Oct 08;13:940 27855693 - BMC Med. 2016 Nov 18;14 (1):187 23743307 - Int J Tuberc Lung Dis. 2013 Jul;17(7):866-77 16546541 - Lancet. 2006 Mar 18;367(9514):926-37 28163165 - Int J Infect Dis. 2017 Mar;56:14-20 25194886 - Lancet Diabetes Endocrinol. 2014 Sep;2(9):730-9 26867835 - Chest. 2016 Feb;149(2):516-25 27720688 - Lancet Glob Health. 2016 Nov;4(11):e806-e815 16735291 - Sex Transm Infect. 2006 Jun;82 Suppl 3:iii34-40 21740663 - Int J Tuberc Lung Dis. 2011 Aug;15(8):996-1004 25803164 - J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):365-76 27720689 - Lancet Glob Health. 2016 Nov;4(11):e816-e826 27199387 - Am J Epidemiol. 2016 Jun 15;183(12 ):1138-48 24878110 - J Theor Biol. 2014 Oct 7;358:74-84 12742798 - Arch Intern Med. 2003 May 12;163(9):1009-21 21483732 - PLoS One. 2011 Apr 04;6(4):e17601 26482413 - Sci Rep. 2015 Oct 20;5:15468 15249694 - Sex Transm Infect. 2004 Aug;80 Suppl 1:i14-18 18823268 - Clin Infect Dis. 2008 Nov 1;47(9):1135-42 20929855 - Sex Transm Infect. 2010 Dec;86 Suppl 2:ii3-10 15249695 - Sex Transm Infect. 2004 Aug;80 Suppl 1:i19-24 |
| References_xml | – volume-title: Global Tuberculosis Report 2014 year: 2014 ident: 2648_CR2 – ident: 2648_CR6 – ident: 2648_CR23 doi: 10.1016/S0140-6736(01)06076-7 – ident: 2648_CR47 – ident: 2648_CR24 – ident: 2648_CR45 – ident: 2648_CR4 – ident: 2648_CR33 doi: 10.1136/sti.2004.010157 – volume-title: Global Tuberculosis Report 2016 year: 2016 ident: 2648_CR1 – volume: 149 start-page: 516 year: 2016 ident: 2648_CR15 publication-title: Chest doi: 10.1016/j.chest.2015.11.017 – ident: 2648_CR26 doi: 10.1128/CMR.00042-10 – ident: 2648_CR42 doi: 10.1186/1471-2458-13-97 – ident: 2648_CR37 doi: 10.1136/sti.2006.020164 – ident: 2648_CR40 doi: 10.1136/sti.2010.044784 – ident: 2648_CR8 doi: 10.5588/ijtld.12.0573 – ident: 2648_CR30 doi: 10.1001/jama.283.19.2537 – ident: 2648_CR41 doi: 10.1136/sextrans-2012-050640 – ident: 2648_CR21 doi: 10.1183/09031936.00145411 – ident: 2648_CR29 doi: 10.1086/591974 – ident: 2648_CR10 doi: 10.1016/S2214-109X(16)30199-1 – ident: 2648_CR44 doi: 10.7554/eLife.02565 – ident: 2648_CR5 doi: 10.1056/NEJMra1413919 – ident: 2648_CR27 doi: 10.1016/S2213-8587(14)70109-3 – ident: 2648_CR38 doi: 10.1097/QAI.0000000000000605 – volume-title: Global tuberculosis report 2015 year: 2015 ident: 2648_CR3 – ident: 2648_CR36 doi: 10.1136/sti.2004.010165 – ident: 2648_CR17 doi: 10.1016/j.ijid.2017.01.031 – ident: 2648_CR9 doi: 10.1186/s12916-016-0723-2 – ident: 2648_CR32 doi: 10.1093/ije/dyq016 – ident: 2648_CR43 doi: 10.5588/ijtld.11.0062 – ident: 2648_CR46 – ident: 2648_CR25 doi: 10.1093/pch/8.10.624 – ident: 2648_CR22 doi: 10.5588/pha.14.0087 – ident: 2648_CR39 doi: 10.1136/sti.2006.020230 – ident: 2648_CR18 doi: 10.1016/S2214-109X(16)30265-0 – ident: 2648_CR35 doi: 10.1371/journal.pcbi.1000656 – ident: 2648_CR12 doi: 10.1093/aje/kwv323 – ident: 2648_CR14 doi: 10.1016/j.jtbi.2014.05.023 – ident: 2648_CR20 doi: 10.1001/archinte.163.9.1009 – ident: 2648_CR31 doi: 10.1086/338342 – volume: 378 start-page: 515 year: 2011 ident: 2648_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(10)61505-X – ident: 2648_CR19 doi: 10.1016/S0140-6736(06)68383-9 – ident: 2648_CR13 doi: 10.1038/srep15468 – ident: 2648_CR16 doi: 10.1371/journal.pone.0017601 – ident: 2648_CR28 doi: 10.1016/S0140-6736(15)00151-8 – ident: 2648_CR34 doi: 10.1186/1471-2458-13-940 – ident: 2648_CR11 doi: 10.1186/s12916-016-0608-4 – reference: 25194886 - Lancet Diabetes Endocrinol. 2014 Sep;2(9):730-9 – reference: 18823268 - Clin Infect Dis. 2008 Nov 1;47(9):1135-42 – reference: 21483732 - PLoS One. 2011 Apr 04;6(4):e17601 – reference: 20929855 - Sex Transm Infect. 2010 Dec;86 Suppl 2:ii3-10 – reference: 24103508 - BMC Public Health. 2013 Oct 08;13:940 – reference: 16735294 - Sex Transm Infect. 2006 Jun;82 Suppl 3:iii51-55 – reference: 27855693 - BMC Med. 2016 Nov 18;14 (1):187 – reference: 23374118 - BMC Public Health. 2013 Feb 02;13:97 – reference: 27720688 - Lancet Glob Health. 2016 Nov;4(11):e806-e815 – reference: 21740663 - Int J Tuberc Lung Dis. 2011 Aug;15(8):996-1004 – reference: 25803164 - J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):365-76 – reference: 23172341 - Sex Transm Infect. 2012 Dec;88 Suppl 2:i11-6 – reference: 20126529 - PLoS Comput Biol. 2010 Jan 29;6(1):e1000656 – reference: 26867835 - Chest. 2016 Feb;149(2):516-25 – reference: 16546541 - Lancet. 2006 Mar 18;367(9514):926-37 – reference: 24898755 - Elife. 2014 Jun 04;3:null – reference: 27199387 - Am J Epidemiol. 2016 Jun 15;183(12 ):1138-48 – reference: 20348129 - Int J Epidemiol. 2010 Apr;39 Suppl 1:i7-10 – reference: 20019856 - Paediatr Child Health. 2003 Dec;8(10):624-6 – reference: 11567729 - Lancet. 2001 Sep 15;358(9285):912-6 – reference: 24021245 - Health Technol Assess. 2013 Sep;17 (37):1-372, v-vi – reference: 15249694 - Sex Transm Infect. 2004 Aug;80 Suppl 1:i14-18 – reference: 11807725 - J Infect Dis. 2002 Feb 1;185(3):401-4 – reference: 21481448 - Lancet. 2011 Aug 6;378(9790):515-25 – reference: 10815117 - JAMA. 2000 May 17;283(19):2537-45 – reference: 26482413 - Sci Rep. 2015 Oct 20;5:15468 – reference: 22005924 - Eur Respir J. 2012 Jun;39(6):1425-31 – reference: 15249695 - Sex Transm Infect. 2004 Aug;80 Suppl 1:i19-24 – reference: 23743307 - Int J Tuberc Lung Dis. 2013 Jul;17(7):866-77 – reference: 12742798 - Arch Intern Med. 2003 May 12;163(9):1009-21 – reference: 21482729 - Clin Microbiol Rev. 2011 Apr;24(2):351-76 – reference: 27012808 - BMC Med. 2016 Mar 24;14 :56 – reference: 28163165 - Int J Infect Dis. 2017 Mar;56:14-20 – reference: 27720689 - Lancet Glob Health. 2016 Nov;4(11):e816-e826 – reference: 16735291 - Sex Transm Infect. 2006 Jun;82 Suppl 3:iii34-40 – reference: 24878110 - J Theor Biol. 2014 Oct 7;358:74-84 |
| SSID | ssj0017829 |
| Score | 2.2675045 |
| Snippet | Background
Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new... Tuberculosis (TB) is now the world's leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB... Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new... Abstract Background Tuberculosis (TB) is now the world’s leading infectious killer and major programmatic advances will be needed if we are to meet the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 546 |
| SubjectTerms | Antigens Complexity Computer programs Computer simulation Cost-Benefit Analysis Development and progression Disease Disease transmission Disease transmission, infectious Drug resistance Drug resistance in microorganisms Economic models Epidemics Epidemiology Global health Heterogeneity Humans Immunization Infection Control - methods Infectious Diseases Internal Medicine Mathematical models Medical Microbiology Medicine Medicine & Public Health Models, biological Models, Economic Models, Theoretical Modular construction Modular engineering Modules Object oriented programming Open source software Parasitology Programming Public health Risk groups Software Software engineering Trends Tropical Medicine Tuberculosis Tuberculosis - economics Tuberculosis - epidemiology Tuberculosis - prevention & control Tuberculosis - transmission Tuberculosis and other mycobacterial diseases Tuberculosis, multidrug-resistant Vaccination |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIISEeJRXoKCAkJCAqHnazgktiAISWxCUam-Wn2WlJVk2G879IfDn-kuYSbxLU9ReuMYTyZ4Zz3xjj2cIeeJil8UmVpG0qYIARetIZqWKXOFYVlpqTd-15APb3eWTSfnJH7g1Pq1yZRM7Q21qjWfk2wA0wNeDd41fzn9E2DUKb1d9C43z5AK2zUY9Z5N1wJWA9yv9TWbC6XYDtphhdhDr8roiOvBFXcn-fw3zMc90MmvyxNVp55F2rv3vWq6Tqx6LhqNeeW6Qc7baJJfG_rZ9k1zpz_TC_qnSTfJ2XBvMWg19Utd3mFYIoDdctsoudDurm2kT-uT3FyFAy_Do8Neo3WvHu0eHv8P5TC4RI98iX3fe7L1-F_lGDJGmLFlGZZmqgieSM8OBk87FknNHjUyVVqbgVHOj8jLJZFkoDoCMSaoYzY1LaWpskt0mG1Vd2bskZEWRaqWlVBDIUJ5JwAhKW5llquQyZQGJVyIR2lcpx2YZM9FFK5yKXooCpChQioIG5Nn6l3lfouMs4lco5zUhVtfuPtSLA-E3qzAJpdKk2gL8ylXmJM0VNzA_S11uVBKQx6glAutnVJigcyDbphHvP-6LEQJYmoOLOY3oy-cB0VNP5GpYppb-UQQwC-tyDSi3BpRgBfRweKVqwluhRvzVs4A8Wg_jn5hZV9m6RRoAsIBTkzIgd3oFXzMHeNfF_wFhA9UfcG84Uk2_dTXKAaVCoJoF5Plqkxyb1mnCuXf2Iu6TyyluXkzYYVtkY7lo7QNyUf9cTpvFw27r_wG3cmF5 priority: 102 providerName: ProQuest – databaseName: Springer Nature Link Journals dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELWgIMQL90ugoICQkKARSZzYzuOCKCCxC2pL1TfL17LSklSbhOd-CPxcv4Rx4kRNoUjwGo8jZzLjOaM5HiP0zMYWxzqWkTCphARFqUjgQkY2txQXhhjd31rykS4W7OCg-OzPcdcD230oSXY7defWjLyqYSeljttDO1ZWRC6iSxDtmLuvYWd3fywdQMgrfPnyj9MmAajr0__7bnwqHJ2lSp6pl3ZhaPv6f33ADXTNo85w1pvJTXTBlLfQlbmvq99G7-aVdnzU0NO1vsF7Q4CzYdNKs1btqqqXdehp7VshgMbw5PjHrN1r54uT45_h0Uo0Dv3eQV-23-69eR_5KxYiRWjSREWRypwlglHNYJHWxoIxS7RIpZI6Z0QxLbMiwaLIJQOoRQWRlGTapiTVJsF30UZZleY-Cmmep0oqISSkKIRhAdFfKiMwlgUTKQ1QPOidK99_3F2DseJdHsII7xXEQUHcKYiTAL0Ypxz1zTf-Jvza_cxR0PXN7h5U60Pu3ZDrhBChU2UAWGUSW0EyyTSszxCbaZkE6KkzBe46Y5SOenMo2rrmHz7t85mDpiSD4HGe0O7OROi5F7IVfKYS_rgDKMt13JpIbk4kwb_VdHgwS-73l5oD7AbkC1gzDtCTcdjNdJy50lStkwFoCgg0KQJ0r7fiUTmguy6zDxCd2PdEe9ORcvm16z4O-BNSUBygl4OVn1rWeT_nwT9JP0RXU-cmjplDN9FGs27NI3RZfW-W9fpx5-6_AK1DUjg priority: 102 providerName: Springer Nature |
| Title | Modular programming for tuberculosis control, the “AuTuMN” platform |
| URI | https://link.springer.com/article/10.1186/s12879-017-2648-6 https://www.ncbi.nlm.nih.gov/pubmed/28784094 https://www.proquest.com/docview/1934568930 https://www.proquest.com/docview/1927306319 https://pubmed.ncbi.nlm.nih.gov/PMC5547473 https://doaj.org/article/d166ad2ce7104b3fa64b8d98ae6f4db1 |
| Volume | 17 |
| WOSCitedRecordID | wos000407072100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ProQuest Central (subscription) customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: 8C1 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1471-2334 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017829 issn: 1471-2334 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtNAFB1BQYgN4o2hRAYhIQFW_ZzHMq1aqERClJYqrEbzpJFSp4pj1v0Q-Ll-CXfsSRQXFTZsLNlzbdln7sw9V3N8B6E3NrZZrGMZCZNKSFCUikTGZGQLSzJmsNHtriWfyXBIJxM22tjqy2nC2vLALXA7OsFY6FQZCIW5zKzAuaSaUWGwzbVsEp-YsFUy5dcPIO4xv4aZULxTwSxMnC6INIquCHeiUFOs_88peSMmXdVLXlk0bWLRwX10z5PIsN--_AN0w5QP0Z2BXyZ_hD4O5trJS0OvvjqDp4TATsNlLc1C1bN5Na1Cr1L_EAIHDC8vfvbr43owvLz4FZ7PxNKR2cfo68H-8d6nyO-YEClMkmXEWCoLmghKNIUPtzYWlFqsRSqV1AXFimqZsyQTrJAUmBMRWBKca5viVJske4K2ynlpnqGQFEWqpBJCQsaBaSYgmEtlRJZJAD8lAYpXCHLly4m7XS1mvEkrKOYt6BxA5w50jgP0bn3LeVtL42_Gu65b1oauDHZzAZyDe-fg_3KOAL12ncpdoYvSKWm-i7qq-OGXE953TBPnEAuuMzoad4zeeiM7h89Uwv-9AGC5Alody-2OJQxX1W1eORj300XFgUUDkQXqGAfo1brZ3ekkcKWZ184GmCYQyoQF6Gnrj2twALsmUQ8Q6XhqB71uSzk9bYqJA52EjDIL0PuVT2-81nWd8_x_dM4LdDd1I9Lpb8g22louavMS3VY_ltNq0UM3yYQ0RwpHupf00K3d_eFo3GtGOpyNDgejb3A2Pjr5DWAuVqk |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEB2VFAES4lJuhgIGgZAAq_FtvX5AKFxKozZpBAGVp2VvLpGCHeIYxFs_BH6Bj-qXMGs7oS5q3_rAa3YcecezM2d2z84APEjaid9WbeFw7QlMUKR0uB8LJwmTyI810arqWrIV9ft0ZyceLMHv-V0YQ6uc-8TSUatMmj3yNQQaGOsxurafT746pmuUOV2dt9CozGJT__iOKVv-rPsKv-9Dz1t_PXy54dRdBRxJInfmxLEnQupyGimK6DpJ2pzShCjuCSlUSImkSgSx6_M4FBTRRcSJiEigEo94Srs-_u8pWA6MsbdgedDtDT4uzi0w3sb12alLyVqO3j8yfKSoZJI5pBH9yiYB_4aCA7HwME_z0GFtGQPXL_5v2rsEF2q0bXeq5XEZlnS6Amd6NZ9gBc5Xu5Z2dRnrCrzpZcrwcu2atvYF1WAjrLdnhdBTWYyzfJTbNb3_qY3g2d7f-9kphkWvv7_3y56M-cxkAVfh_YlM6xq00izVN8COwtCTQnIuMFUj1OeIgoTU3PdFTLkXWdCemwCTdR120w5kzMp8jBJWWQ1Dq2HGahix4PHikUlVhOQ44RfGrhaCpn54-UM23WW1O2LKJYQrT2oEmIHwE04CQRW-nyZJoIRrwX1jlcxUCEkNBWmXF3nOutsfWMdAdBJgED1K6N3bhtCjWijJcJqS19c-UFmm8lhDcrUhiX5ONofnps1qP5uzv3Ztwb3FsHnScAdTnRVGBiE6InE3tuB6taAWykHdlTscFkSNpdbQXnMkHX0uq7AjDsdU3LfgyXxRHnitoz7OzeMncRfObgx7W2yr29-8Bec84zgMPSlahdZsWujbcFp-m43y6Z3a8djw6aRX6x-kHr_s |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bbtQwELWgoIoX7tBAgYCQkICoudrO43JZqOguFS1V3yxf25WWZLVJeO6HwM_1SxgnzqopFAnxGo8Vezz2nNEcjxF6bkKThCoUAdexgABFyoAnuQhMZkiSa6xV92rJDplO6eFhvuveOa16tnufkuzuNNgqTUW9tVCm2-IUb1VwqhLL8yEtQyvAl9GV1PLobbi-d7BKI4D7y10q84_dBs6ordn_-8l8xjWdp02ey522Lml8478ncxNdd2jUH3Xmcwtd0sVttD5x-fY76MOkVJan6jsa1zf4hw8w168boZeymZfVrPId3f21D2DSPz35MWr2m8n09OSnv5jz2qLiu-jr-P3-24-Be3ohkJhEdZDnschoxClRFAZpTMgpNVjxWEihMoolVSLNo4TnmaAAwQjHguBUmRjHSkfJPbRWlIXeQD7JslgKybmA0AXThAMqEFLzJBE55THxUNivAZOuLrl9HmPO2viEYtYpiIGCmFUQwx56ueqy6Ipy_E34jV3YlaCtp91-KJdHzG1PpiKMuYqlBsCVisRwnAqqYHwam1SJyEPPrFkwWzGjsJScI95UFdv-fMBGFrLiFJzKRUJ7XwZCL5yQKWGakrtrEKAsW4lrILk5kIR9L4fNvYkyd-5UDOA4IGLAoKGHnq6abU_LpSt02VgZgKyATKPcQ_c7i14pB3TXRvweIgNbH2hv2FLMjtuq5IBLITRNPPSqt_gzw7pocR78k_QTtL77bsx2tqefHqJrsd0xlrxDNtFavWz0I3RVfq9n1fJxewr8AstUXgA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modular+programming+for+tuberculosis+control%2C+the+%22AuTuMN%22+platform&rft.jtitle=BMC+infectious+diseases&rft.au=Trauer%2C+James+McCracken&rft.au=Ragonnet%2C+Romain&rft.au=Doan%2C+Tan+Nhut&rft.au=McBryde%2C+Emma+Sue&rft.date=2017-08-07&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12879-017-2648-6&rft.externalDocID=A511264762 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |